Healthcare reforms required globally to match progress in diagnosis, treatment of Alzheimer’s disease: Researchers

NEW DELHI: (Sep 23) A rapid reform to healthcare systems, public policy and attitude in society would be required to address burden of Alzheimer’s disease in population, even as medications and blood tests present a potential in diagnosis and treatment, researchers say in a Lancet Series.

Alzheimer’s disease — the most common form of dementia — is an ageing-related neurological disorder which steadily impacts one’s memory and thought processes, eventually interfering with daily activities.

Describing new treatments and diagnostic methods for the condition in a series of three papers in The Lancet journal, the international team of researchers said that medications — lecanemab and donanemab — could slow down Alzheimer’s disease from advancing.

Source: PTI News

Digitalmitra